[18F]JNJ-42259152

N/A

Report date: 2025/11/24 11:49:26

Base Information

Drug Name[18F]JNJ-42259152
Drug Alias Name[18F]JNJ-42259152
ClassificationSmall moleculesRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Nuclides > Fluorine > 18F +[5] 
Mechanisms of ActionPhosphodiesterase 10A inhibitors
TargetsPhosphodiesterase 10A
Therapy Area/IndicationsDiagnostic agents
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesJohnson & Johnson Innovative Medicine
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesJohnson & Johnson Innovative Medicine
Active IndicationsN/A
Inactive IndicationsDiagnostic agents

Other Information

ATC CodeN/A
Related LinksN/A